$EBS
Emergent BioSolutions Inc.

2020 Q4 Form 10-Q Financial Statement

#000136764420000163 Filed on November 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $583.0M $385.2M $360.4M
YoY Change 61.76% 23.54% 33.14%
Cost Of Revenue $164.8M $149.0M $132.8M
YoY Change 24.1% 37.96% 30.32%
Gross Profit $418.2M $236.2M $77.80M
YoY Change 437.53% 234.09% 594.64%
Gross Profit Margin 71.73% 61.32% 21.59%
Selling, General & Admin $82.10M $75.50M $72.20M
YoY Change 13.71% 16.15% -10.53%
% of Gross Profit 19.63% 31.96% 92.8%
Research & Development $59.50M $84.40M $62.80M
YoY Change -5.25% 58.05% 20.77%
% of Gross Profit 14.23% 35.73% 80.72%
Depreciation & Amortization $28.90M $28.80M $27.90M
YoY Change 3.58% 3.97% 11.16%
% of Gross Profit 6.91% 12.19% 35.86%
Operating Expenses $156.6M $159.9M $149.8M
YoY Change 4.54% -33.68% -4.95%
Operating Profit $258.1M $61.30M $77.80M
YoY Change 231.75% -13.3% -153.14%
Interest Expense -$8.700M $7.600M -$9.100M
YoY Change -4.4% -26.21% -1.09%
% of Operating Profit -3.37% 12.4% -11.7%
Other Income/Expense, Net $3.400M -$6.300M $2.900M
YoY Change 17.24% -46.61% 81.25%
Pretax Income $252.8M $55.00M $71.50M
YoY Change 253.57% -6.62% 1942.86%
Income Tax $67.40M $15.50M $24.60M
% Of Pretax Income 26.66% 28.18% 34.41%
Net Earnings $185.4M $39.50M $46.90M
YoY Change 295.31% -8.56% -1479.41%
Net Earnings / Revenue 31.8% 10.25% 13.01%
Basic Earnings Per Share $3.51 $0.75 $0.91
Diluted Earnings Per Share $3.44 $0.73 $0.90
COMMON SHARES
Basic Shares Outstanding 53.00M shares 53.00M shares 51.62M shares
Diluted Shares Outstanding 54.30M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $621.3M $415.0M $167.8M
YoY Change 270.26% 198.13% 49.55%
Cash & Equivalents $621.3M $415.0M $167.8M
Short-Term Investments
Other Short-Term Assets -$4.400M $77.60M $20.60M
YoY Change -121.36% 57.09% -35.02%
Inventory $307.0M $270.1M $222.5M
Prepaid Expenses
Receivables $230.9M $196.1M $270.7M
Other Receivables $0.00 $0.00 $4.600M
Total Short-Term Assets $1.196B $958.8M $686.2M
YoY Change 74.28% 36.97% 10.53%
LONG-TERM ASSETS
Property, Plant & Equipment $644.1M $606.5M $542.3M
YoY Change 18.77% 14.63% 6.29%
Goodwill $266.7M $266.5M $266.6M
YoY Change 0.04% -0.78% 2.66%
Intangibles $663.1M $678.1M $712.9M
YoY Change -6.99% -6.82% -6.39%
Long-Term Investments
YoY Change
Other Assets $113.4M $106.4M $90.30M
YoY Change 25.58% 57.86% 559.12%
Total Long-Term Assets $1.687B $1.658B $1.641B
YoY Change 2.82% 1.45% 2.02%
TOTAL ASSETS
Total Short-Term Assets $1.196B $958.8M $686.2M
Total Long-Term Assets $1.687B $1.658B $1.641B
Total Assets $2.883B $2.616B $2.327B
YoY Change 23.89% 12.1% 4.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $136.1M $102.8M $94.80M
YoY Change 43.57% 12.6% 17.47%
Accrued Expenses $46.90M $34.90M $39.50M
YoY Change 18.73% -32.63% 28.66%
Deferred Revenue $44.60M $3.300M
YoY Change 1251.52%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $33.80M $30.90M $12.90M
YoY Change 162.02% 205.94% 27.72%
Total Short-Term Liabilities $384.5M $299.3M $216.3M
YoY Change 77.76% 8.72% 7.93%
LONG-TERM LIABILITIES
Long-Term Debt $841.0M $848.5M $798.4M
YoY Change 5.34% 4.33% 1.77%
Other Long-Term Liabilities $67.80M $57.40M $48.60M
YoY Change 39.51% 8.3% -1.22%
Total Long-Term Liabilities $908.8M $905.9M $847.0M
YoY Change 7.3% 4.57% 1.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $384.5M $299.3M $216.3M
Total Long-Term Liabilities $908.8M $905.9M $847.0M
Total Liabilities $1.436B $1.365B $1.239B
YoY Change 15.93% 5.08% 1.67%
SHAREHOLDERS EQUITY
Retained Earnings $726.9M $541.5M $421.8M
YoY Change 72.33% 44.44% 14.84%
Common Stock $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $39.60M $39.60M $39.60M
YoY Change 0.0% -0.25% 0.0%
Treasury Stock Shares 1.200M shares 1.200M shares 1.200M shares
Shareholders Equity $1.447B $1.252B $1.089B
YoY Change
Total Liabilities & Shareholders Equity $2.883B $2.616B $2.327B
YoY Change 23.89% 12.1% 4.39%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income $185.4M $39.50M $46.90M
YoY Change 295.31% -8.56% -1479.41%
Depreciation, Depletion And Amortization $28.90M $28.80M $27.90M
YoY Change 3.58% 3.97% 11.16%
Cash From Operating Activities $245.1M $105.2M $122.1M
YoY Change 100.74% -3493.55% -173.64%
INVESTING ACTIVITIES
Capital Expenditures -$36.00M -$45.70M -$36.10M
YoY Change -0.28% 198.69% 73.56%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$36.00M -$45.70M -$36.10M
YoY Change -0.28% 198.69% -95.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.300M 87.10M -57.90M
YoY Change -96.03% -542.13% -107.37%
NET CHANGE
Cash From Operating Activities 245.1M 105.2M 122.1M
Cash From Investing Activities -36.00M -45.70M -36.10M
Cash From Financing Activities -2.300M 87.10M -57.90M
Net Change In Cash 206.8M 146.6M 28.10M
YoY Change 635.94% -484.78% -112.31%
FREE CASH FLOW
Cash From Operating Activities $245.1M $105.2M $122.1M
Capital Expenditures -$36.00M -$45.70M -$36.10M
Free Cash Flow $281.1M $150.9M $158.2M
YoY Change 77.69% 1136.89% -209.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001367644
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssets
CY2020Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:LiabilitiesCurrentAbstract
CY2020Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020Q3 ebs Debt Instrument Covenant Net Leverage Ratio Adjustment Period
DebtInstrumentCovenantNetLeverageRatioAdjustmentPeriod
P12M
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33137
dei Entity Shell Company
EntityShellCompany
false
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Professional Drive Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
Gaithersburg,
dei Entity Registrant Name
EntityRegistrantName
EMERGENT BIOSOLUTIONS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
14-1902018
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20879
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
631-3200
dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.001 per share
dei Trading Symbol
TradingSymbol
EBS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52999139 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
415000000.0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
167800000 USD
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000 USD
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
196100000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
270700000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
270100000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
222500000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
77400000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25000000.0 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
958800000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
686200000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
606500000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
542300000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
678100000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
712900000 USD
CY2020Q3 ebs In Process Research And Development
InProcessResearchAndDevelopment
0 USD
CY2019Q4 ebs In Process Research And Development
InProcessResearchAndDevelopment
29000000.0 USD
CY2020Q3 us-gaap Goodwill
Goodwill
266500000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
266600000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106400000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
90300000 USD
CY2020Q3 us-gaap Assets
Assets
2616300000 USD
CY2019Q4 us-gaap Assets
Assets
2327300000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
102800000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
94800000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
34900000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39500000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
76900000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62400000 USD
CY2020Q3 us-gaap Notes Payable Current
NotesPayableCurrent
30900000 USD
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
12900000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
53800000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6700000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
299300000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
216300000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
35200000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
26000000.0 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
848500000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
798400000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
64000000.0 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
63900000 USD
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
60400000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
85600000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
57400000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
48600000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
1364800000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1238800000 USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000.0 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000.0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54200000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53000000.0 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53000000.0 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51700000 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1200000 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1200000 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
39600000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
39600000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
770900000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
716100000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21400000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9900000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
541500000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
421800000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1251500000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1088500000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2616300000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2327300000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
385200000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311800000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
972400000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
745700000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
149000000.0 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108000000.0 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
355700000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
300700000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
84400000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53400000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
175000000.0 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
36400000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
163400000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75500000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65000000.0 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
221200000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
201300000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000000.0 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14700000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44800000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43900000 USD
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
323900000 USD
CY2019Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
241100000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
796700000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
709300000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
61300000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
70700000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
175700000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
7600000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
10300000 USD
us-gaap Interest Expense
InterestExpense
22600000 USD
us-gaap Interest Expense
InterestExpense
29300000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1300000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1500000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1300000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1200000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6300000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11800000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-21300000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30500000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
55000000.0 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
58900000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
154400000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5900000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15500000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1700000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
39500000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
43200000 USD
us-gaap Net Income Loss
NetIncomeLoss
119700000 USD
us-gaap Net Income Loss
NetIncomeLoss
7600000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53000000.0 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51400000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54300000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53600000 shares
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
39500000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
43200000 USD
us-gaap Net Income Loss
NetIncomeLoss
119700000 USD
us-gaap Net Income Loss
NetIncomeLoss
7600000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-200000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1100000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-600000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
600000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1000000.0 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-3000000.0 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-10900000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11500000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3600000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-4200000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
800000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4100000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
40300000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39100000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
108200000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4000000.0 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-200000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
3400000 USD
us-gaap Net Income Loss
NetIncomeLoss
119700000 USD
us-gaap Net Income Loss
NetIncomeLoss
7600000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
41000000.0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
21000000.0 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
85600000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
82800000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
29000000.0 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
ebs Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
31300000 USD
ebs Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
12400000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2400000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2200000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4400000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5700000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-600000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-700000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-74600000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18600000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
47600000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24400000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
61800000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
36500000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10600000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2500000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4400000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5200000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
14500000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2400000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-9000000.0 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
19100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
290900000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
65900000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
105000000.0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50800000 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
10000000.0 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
10000000.0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-115000000.0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60800000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
130000000.0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
373000000.0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
95000000.0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
450000000.0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
8400000 USD
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
8400000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8400000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26600000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5700000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12800000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6600000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
2200000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3700000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71800000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22000000.0 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-500000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-100000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
247200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
27000000.0 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168000000.0 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112400000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
415200000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139400000 USD
us-gaap Interest Paid Net
InterestPaidNet
14000000.0 USD
us-gaap Interest Paid Net
InterestPaidNet
27600000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
87300000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
21200000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9700000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18100000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
415000000.0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
167800000 USD
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000 USD
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
415200000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168000000.0 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1088500000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
54800000 USD
us-gaap Net Income Loss
NetIncomeLoss
119700000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11500000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1251500000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1198800000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12400000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
39500000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
800000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1251500000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1010900000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20100000 USD
us-gaap Net Income Loss
NetIncomeLoss
7600000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3600000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1035000000.0 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
988900000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000000.0 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
43200000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4100000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1035000000.0 USD
ebs Number Of Categories Of Public Health Threats
NumberOfCategoriesOfPublicHealthThreats
5 category
ebs Number Of Revenue Generating Products
NumberOfRevenueGeneratingProducts
10 product
ebs Number Of Product Candidates
NumberOfProductCandidates
2 productCandidate
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
290800000 USD
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
52200000 USD
CY2020Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
116800000 USD
CY2019Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
70500000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
104300000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
89700000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
49000000.0 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
62300000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
270100000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
222500000 USD
CY2020Q3 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
13800000 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
853400000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
752700000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
246900000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
210400000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
606500000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
542300000 USD
CY2020Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
ebs Lessee Operating Lease Termination Period
LesseeOperatingLeaseTerminationPeriod
P1Y
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1100000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
800000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3200000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2100000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000 USD
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
800000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
400000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
1300000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
900000 USD
us-gaap Lease Cost
LeaseCost
4000000.0 USD
us-gaap Lease Cost
LeaseCost
2500000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23400000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24700000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4400000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3600000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20700000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22100000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
25100000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
25700000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M24D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
832100000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
154000000.0 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
678100000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
822100000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
109200000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
712900000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44800000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43900000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000000.0 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14700000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P13Y
CY2020Q3 us-gaap Goodwill
Goodwill
266500000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
266600000 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
29200000 USD
ebs Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Change In Fair Value
FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue
31300000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
2200000 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
58300000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
891100000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
822500000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
30900000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12900000 USD
CY2020Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
11700000 USD
CY2019Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
11200000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
848500000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
798400000 USD
CY2019Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
1800000 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5000000.0 USD
CY2020Q3 ebs Debt Instrument Covenant Net Leverage Ratio Rolling Period
DebtInstrumentCovenantNetLeverageRatioRollingPeriod
P12M
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
385200000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311800000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
972400000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
745700000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
88900000 USD
ebs Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
60000000.0 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
69000000.0 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
79900000 USD
CY2020Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y6M
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
18100000 USD
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
18100000 USD
CY2019Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
0 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
0 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2200000000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2020Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
40800000 USD
CY2019Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
34000000.0 USD
CY2020Q3 us-gaap Billed Contract Receivables
BilledContractReceivables
166000000.0 USD
CY2019Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
227300000 USD
CY2020Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
30100000 USD
CY2019Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
43400000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
196100000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
39500000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
270700000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
700000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.29
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.27
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.25
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.24
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
9900000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2900000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3300000 USD
CY2019Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-200000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
43200000 USD
us-gaap Net Income Loss
NetIncomeLoss
119700000 USD
us-gaap Net Income Loss
NetIncomeLoss
7600000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53000000.0 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51400000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1300000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
700000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1100000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
900000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54300000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52300000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000.0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000.0 shares
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10000000.0 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6100000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41000000.0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21000000.0 USD

Files In Submission

Name View Source Status
0001367644-20-000163-index-headers.html Edgar Link pending
0001367644-20-000163-index.html Edgar Link pending
0001367644-20-000163.txt Edgar Link pending
0001367644-20-000163-xbrl.zip Edgar Link pending
a1010-hhso.htm Edgar Link pending
a1011-admdpas.htm Edgar Link pending
a1012-azmaster.htm Edgar Link pending
a1013-azproductschedule.htm Edgar Link pending
a1014-azminixmsa.htm Edgar Link pending
a1015-azmsaamend.htm Edgar Link pending
a1016-janssenagreement.htm Edgar Link pending
a103-hhsmod6.htm Edgar Link pending
a104-mod21.htm Edgar Link pending
a105-mod22.htm Edgar Link pending
a106-mod23.htm Edgar Link pending
a107-mod24.htm Edgar Link pending
a108-mod25.htm Edgar Link pending
a109-dpas.htm Edgar Link pending
a311-kramercert.htm Edgar Link pending
a312-lindhalcert.htm Edgar Link pending
a321-kramercert.htm Edgar Link pending
a322-lindhalcert.htm Edgar Link pending
ebs-20200930.htm Edgar Link pending
ebs-20200930.xsd Edgar Link pending
ebs-20200930_cal.xml Edgar Link unprocessable
ebs-20200930_def.xml Edgar Link unprocessable
ebs-20200930_g1.jpg Edgar Link pending
ebs-20200930_g2.jpg Edgar Link pending
ebs-20200930_g3.jpg Edgar Link pending
ebs-20200930_g4.jpg Edgar Link pending
ebs-20200930_g5.jpg Edgar Link pending
ebs-20200930_g6.jpg Edgar Link pending
ebs-20200930_g7.jpg Edgar Link pending
ebs-20200930_g8.jpg Edgar Link pending
ebs-20200930_htm.xml Edgar Link completed
ebs-20200930_lab.xml Edgar Link unprocessable
ebs-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_01.jpg Edgar Link pending
image_11.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending